Lupin

Lupin ROIC

The Return on Invested Capital (ROIC) of Lupin (LUPIN.NS) as of Nov 3, 2026 is 23.76 %. In the previous year, Return on Invested Capital (ROIC) was 14.49 % — a change of 63.98% (higher).

ROIC

23.76 %

YoY

63.98%

Last updated:

Return on Invested Capital (ROIC) of Lupin is 2026 23.76 % . Return on Invested Capital (ROIC) of Lupin was 2025 14.49 % . It decreases by 63.98% higher compared to the previous year.

The Lupin ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2019
2.73 INR
Jan 1, 2020
-1.41 INR
Jan 1, 2021
6.43 INR
Jan 1, 2022
-9.37 INR
Jan 1, 2023
2.53 INR
Jan 1, 2024
11.12 INR
Jan 1, 2025
14.49 INR
Jan 1, 2026
23.76 INR
The Lupin ROIC history
YEARROICYoY
23.76 %+63.98%
14.49 %+30.25%
11.12 %+339.82%
2.53 %-127.00%
-9.37 %-245.78%
6.43 %-557.07%
-1.41 %-151.54%
2.73 %+124.92%
1.21 %-89.82%
11.92 %-3.33%
12.33 %-51.73%
25.54 %-20.44%
32.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lupin Stock analysis

What does Lupin do? Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lupin stock

Return on Invested Capital (ROIC) of Lupin is 23.76 % in 2026.

Return on Invested Capital (ROIC) of Lupin changed from 14.49 % to 23.76 %, representing a 63.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Lupin since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Lupin with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Lupin

All Key Metrics — Lupin